The annual State of the School was presented on Wednesday, January 26, by Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System.
The annual presentation provides an update on Icahn Mount Sinai’s recent accomplishments in advancing medical research, educating the future leaders of health care, and serving the community. During the second year of the COVID-19 pandemic, the presentation was again delivered on video. It can be viewed here.
The State of the School included initiatives aimed at improving the lives of patients, which include new areas of investment in research and newly established Institutes, Departments, and Centers. Dr. Charney also highlighted the School’s focus on innovation and entrepreneurship, and efforts to make Icahn Mount Sinai a more equitable and anti-racist institution.
The past year included new opportunities for the members of the Icahn Mount Sinai community to support patients and the advancement of medicine. During the State of the School, there was a video tribute to the heroes within the School who contributed to Mount Sinai’s COVID-19 response.
The Department of Neurosurgery has announced promotions and appointments of faculty members across Mount Sinai Health System.
J Mocco, MD, MS
J Mocco, MD, MS, has been promoted to Senior Vice Chair of Neurosurgery, Mount Sinai Health System.
In this new position, Dr. Mocco will work with the Department Chair and clinicians to provide strategic leadership in advancing the Department of Neurosurgery’s 10 service lines across the Health System. These include cerebrovascular, skull base, malignant brain tumors, pituitary/neuroendocrine, spine, neuromodulation, epilepsy, pediatrics, trauma, and neurocritical care.
Since joining the Department, Dr. Mocco has served as Vice Chair of Neurosurgery and Director of the Neurosurgery Residency Program. He is Director of the Cerebrovascular Center and Co-Director of the Neuroendovascular Fellowship Program. In these roles, Dr. Mocco developed the stroke coverage model for NYC Health + Hospitals/Elmhurst and the Mount Sinai Queens stroke suite program. This initiative established a novel care pathway that is already delivering dramatic improvements for stroke care. Dr. Mocco has also directed the opening of thrombectomy and diagnostic neurointerventional services at Mount Sinai Brooklyn. He has gained international recognition for his extensive stroke research as a key thought leader and Principal Investigator in many pivotal clinical trials.
Dr. Mocco received his medical degree from the Columbia University College of Physicians and Surgeons. He completed his Master of Science in Biostatistics at the Mailman School of Public Health at Columbia University, a residency in neurological surgery at the Neurological Institute of New York, and a fellowship in endovascular neurosurgery at the University of Buffalo.
Isabelle M. Germano, MD, MBA
Isabelle M. Germano, MD, MBA, has been promoted to Vice Chair of Diversity, Equity, and Inclusion for the Department of Neurosurgery, Mount Sinai Health System. Dr. Germano will provide leadership and strategic vision and guidance in the integration of diversity and inclusion principles into the structures, policies, and practices of the education and research environments for the Department. She has been recognized nationally and internationally as an innovative champion for diversity and inclusion.
Dr. Germano received her medical degree from the University of Turin Medical School and completed residencies/fellowships at the University of California, San Francisco, the Albert Einstein College of Medicine, the University of Zurich, and the Montreal Neurological Institute. Dr. Germano received her MBA from the New York University Stern School of Business.
Raj K. Shrivastava, MD
Raj K. Shrivastava, MD, has been appointed Vice Chair for Education, Department of Neurosurgery, Mount Sinai Health System, and Director of the Neurosurgery Residency Program at the Icahn School of Medicine at Mount Sinai. Dr. Shrivastava will oversee educational programs throughout the Department of Neurosurgery, including residency and fellowship programs and medical student education and sub-internships. As residency program Director, he will manage the seven-year-long program’s curriculum and establish additional activities that further enrich the experience of the department’s 14 residents both in and out of the operating room. He will also spearhead initiatives and strategies to increase the program’s national exposure and reputation.
Dr. Shrivastava, who previously served as Associate Program Director of the Residency Program, earned his medical degree from the University of Pennsylvania, followed by a residency in neurosurgery at The Mount Sinai Hospital and a fellowship in skull base surgery at Mount Sinai.
Johanna T. Fifi, MD
Johanna T. Fifi, MD, has been appointed Co-Director of the Pediatric Cerebrovascular Disorders Program and Site Director of Cerebrovascular Services at Mount Sinai West. Dr. Fifi will be responsible for continuing to provide world-class care in the diagnosis, treatment, management, and research of pediatric brain vascular malformations, head and neck vascular malformations, aneurysms, and occlusive vascular diseases. She will also be responsible for providing clinical and technical leadership in the development and expansion of Mount Sinai West’s cerebrovascular neurosurgical services, including treating strokes, aneurysms, vascular malformations, and intracerebral hemorrhage. She joined the program as a part of Continuum Health Partners in 2008.
Dr. Fifi earned a combined biomedical engineering and medical degree from Boston University. She performed her medicine internship and neurology residency at Thomas Jefferson University Hospital. Dr. Fifi then completed a fellowship in stroke and cerebrovascular disorders at the National Institutes of Health in Bethesda, Maryland. Dr. Fifi then trained in neuroendovascular surgery at Washington Hospital Center in the District of Columbia and at Columbia University, finishing with a pediatric neurointervention fellowship at Mount Sinai West.
Christopher P. Kellner, MD,
Christopher P. Kellner, MD, has been appointed Associate Program Director of the Neurosurgery Residency Program at Icahn Mount Sinai. Dr. Kellner will support Dr. Shrivastava to develop the seven-year-long residency program’s curriculum and establish additional activities that further enrich the experience of the department’s 14 residents, including initiatives that promote wellness.
Dr. Kellner is an Assistant Professor of Neurosurgery. He received his medical degree from Columbia University College of Physicians and Surgeons and also completed his residency there. He completed a neuroendovascular surgery fellowship at Icahn Mount Sinai. Dr. Kellner has authored more than 120 publications and serves as Principal Investigator on numerous multicenter clinical trials and studies.
Benjamin I. Rapoport, MD, PhD
Benjamin I. Rapoport, MD, PhD, has been appointed Scientific Director of Mount Sinai BioDesign at Icahn Mount Sinai, a medical device incubator at Mount Sinai. The mission of Mount Sinai BioDesign is to help patients by creating technological solutions to medical problems in a way that generates jobs and high-value assets for Mount Sinai while educating a diversified generation of engineers and scientists.
Dr. Rapoport’s mission as scientific director will be to catalyze technological innovation, translation, and commercialization within Mount Sinai. Mount Sinai BioDesign operates as a center of expertise in engineering and project management to enable Mount Sinai physicians and researchers to translate their ideas into commercially viable products and practical solutions to problems in health care.
Dr. Rapoport is also an Assistant Professor of Neurosurgery. As a neurosurgeon in the Skull Base Surgery Center, he specializes in the diagnosis and minimally invasive surgical treatment of skull base pathologies. Dr. Rapoport has extensive scientific training, receiving master’s degrees in physics from Harvard University and mathematics from Oxford University, a PhD in electrical engineering and computer science from the Massachusetts Institute of Technology, and his medical degree from Harvard Medical School. He completed his neurosurgery residency, chief residency, and fellowship training in endovascular neurosurgery and endoscopic skull base surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He has a track record of technology translation in the areas of digital health, including serving as co-founder of Simbionics (acquired by Apple), and of neurotechnology, including serving as a cofounding member of Neuralink.
Arianny Ramirez, right, a Clinical Research Coordinator in the Spinal Cord Injury Program at The Mount Sinai Hospital, demonstrates patient care in a staff training video with physical therapist Alexandra McGivern.
Intersectionality is a crucial consideration as providers treat patients and understand their needs inside and outside health care facilities, said Arianny Ramirez, a Clinical Research Coordinator in the Spinal Cord Injury Program at The Mount Sinai Hospital, who was the featured speaker for a virtual talk hosted by the Office for Diversity and Inclusion (ODI) at Mount Sinai. The session, “Health Care Disparities and Women with Disabilities,” is available here.
The talk was part of the Raising Disability Awareness Virtual Talk Series, launched by ODI in 2020 for Disability Awareness Month, featured speakers from around the Mount Sinai Health System and the community to promote an inclusive and equitable workplace and health care environment for people with disabilities.
Arianny Ramirez
Ms. Ramirez, a woman of color with a physical disability, discussed health care challenges at both a personal level and a population level. She said the health care community must work together to understand the intersection of sexism, racism, and ableism, and its effect on women with disabilities. “The biggest obstacles I face in my life as a woman with a disability are the barriers and limits society places on me,” she said.
After an accidental fall that paralyzed her from the waist down at age 18, Mrs. Ramirez realized that her life and the lives of many others would be easier if the world were designed with disabilities in mind.
According to the Centers for Disease Control and Prevention, about 36 million women in the United States have disabilities. This number is expected to continue growing, says Mrs. Ramirez, and “women with disabilities face more difficulty than women without disabilities in accessing health care screenings.” Routine physical exams, mammogram, Pap smears, sexually transmitted infection (STI) testing, and eye exams are just a few of the screenings that are more challenging to access for women with disabilities.
Physical and attitudinal barriers often prevent this population from seeking and receiving equitable and appropriate health care. The necessary equipment, machinery, and devices to care for these women are not always present in doctors’ offices, Mrs. Ramirez said of clinical care in the United States.
Additionally, stereotypes and discrimination are often directed toward people with disabilities in health care settings, making them feel uncomfortable and excluded, and there are limited training and guidelines in place to address the specific needs of women with disabilities.
“Let’s start with our physical barriers,” Mrs. Ramirez said. “They consist of a lack of adaptive examination tables and scales, inaccessible testing rooms, and inaccessible diagnostic equipment. Over 90 percent of physicians’ offices do not have wheelchair-accessible scales.”
The Mount Sinai Health System is working to address these disparities with a variety of measures, including a course created by the Department of Rehabilitation and Human Performance for Mount Sinai physicians and other providers in fields such as family medicine, internal medicine, obstetrics and gynecology, and emergency medicine. Mount Sinai employees can register for the course, “Improving Health Care Access for Women with Spinal Cord Injury” on Mount Sinai’s PEAK site.
Ultimately, Mrs. Ramirez called for the public to consider the world from a different perspective.
“I invite all of you to just look around your environment. Whether it’s in the office, the structure that you live in, you work in, or your commute, and think ‘what if I did have a disability? What if I did have knee surgery and there wasn’t a lip in the sidewalk that I couldn’t get over or something?’” she said. “Be mindful of the experiences other people are having and remember that a disability can happen to anyone. One can become disabled at any point in your life, and you can be a part of this community in the future as well. If you do your part and advocate for structural change, this can improve the environment around us and open the door for women with disabilities to get the care they need and live their lives.”
Speaking as a woman with a disability and a professional in rehabilitation, Ms. Ramirez called on the health care community to take four measures: Increase professional education, training, and technical assistance so providers understand disability cultural competency; implement new monitoring and accountability laws and practices to increase oversight; use accreditations to ensure health care facilities comply with accessibility guidelines; and create a universal design that can be applied to any facility to care for and welcome people with disabilities uniformly.
“Until ableism becomes a conscious thought in nondisabled people’s minds, only then will true equality be achieved,” she said.
Mount Sinai West earned a High Performing rating, the highest rating available, from U.S. News & World Report in the publication’s inaugural assessment of hospitals that provide obstetrical care. Mount Sinai West, along with Mount Sinai Morningside, which are ranked together, are among 237 of 2,700 hospitals in the United States to receive this rating.
To achieve the High Performing rating for maternity care, hospitals had to excel on multiple metrics that are important to families, including complication rates, C-section rates, whether births were scheduled too early in pregnancy, and breast feeding support for new parents.
Mount Sinai West has a culture that prioritizes low-intervention births and shared decision-making between providers and their pregnant patients and has a longstanding tradition of using midwives. Examples of how the hospital puts this into practice include offering nitrous oxide as an alternative pain-control measure to an epidural and wireless monitoring that enables patients to walk around during labor rather than having to stay in bed.
The labor and delivery unit’s providers are also trained in TeamSTEPPS, a teamwork model developed by the U.S. Department of Defense and the Agency for Healthcare Research and Quality, to optimize patient outcomes by improving communication among providers.
“We are proud to be included in the inaugural edition of Best Hospitals for Maternity Care,” says Holly Loudon, MD, MPH, Site Chair, Obstetrics, Gynecology and Reproductive Medicine, Mount Sinai West. “To be recognized on a national level is a tribute to our outstanding team of obstetrical faculty, nursing staff, and support staff and their dedication to quality, safety, and patient experience.”
Thanks to the outstanding generosity of the Windreich Family Foundation, the Icahn School of Medicine at Mount Sinai will advance its vision of integrating Artificial Intelligence (AI) and machine learning into research and clinical practice to amplify patient-centered care. This multi-million dollar gift will establish the Windreich Department of Artificial Intelligence and Human Health at Mount Sinai.
By establishing one of the first departments devoted to AI in a medical school, this gift represents Mount Sinai’s exceptional commitment to integrating AI throughout the Mount Sinai Health System. It will enable the recruitment of dedicated faculty, novel research initiatives, and the acquisition of any equipment and software that are mission critical to ensuring Mount Sinai continues to lead bold initiatives that embrace the power of technology to accelerate advances in both scientific research and clinical care.
Oversight of the newly named Windreich Department of Artificial Intelligence and Human Health will fall under the purview of its inaugural Chair, Thomas J. Fuchs, Dr.sc, who is also the Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai. The new department was formed under the vision and guidance of Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine. “This gift will ensure Mount Sinai continues to be at the forefront of the AI-driven revolution of health care to the benefit of Mount Sinai’s diverse patient population,” says Dr. Charney.
“Our duty at the new department at Mount Sinai is to ensure that our patients are the main beneficiaries of the enormous impact AI will have on health care,” says Dr. Fuchs. “To realize this vision, we are tremendously grateful for the gift from the Windreich Family Foundation. Mr. Windreich’s forward looking support will allow us to build a unique AI infrastructure at Mount Sinai and attract the world’s leading talent in this space.”
David Windreich, who serves on the Boards of Trustees at Mount Sinai, has a history of supporting AI and big data solutions in health care. His philanthropy extends to naming the Windreich Center for Bioinformatics at Mount Sinai. This Center is singularly focused on developing cutting-edge, web-based software tools and databases to facilitate the collection and analysis of diverse and complex data from human cells and tissues that will inform precise treatments for patients based on their unique genetic makeup. Mr. Windreich is also a former member of the Board of Directors for Sema4, a platform that uses machine learning and AI tools to analyze a database of more than 10 million patient genomic profiles and clinical records. Sema4 spun out of Mount Sinai in 2017 and went public at a $3 billion valuation in 2021.
“We have not yet reached the tipping point of how AI can play a major role in health care,” says Mr. Windreich. “My family is excited to play a role in supporting Mount Sinai’s initiative of being at the forefront of delivering technology solutions that will ultimately improve care and save lives.”
Bernard Camins, MD, Medical Director for Infection Prevention at the Mount Sinai Health System, discusses how to stay safe in your day-to-day routine and clarifies new guidelines from the Centers for Disease Control and Prevention (CDC).
How safe is public transportation? Are there any new measures New Yorkers should take?
As a New Yorker, I take public transportation all the time. I take both Metro North and the subway. I believe that it’s safe, otherwise I wouldn’t be taking them. I agree with the guidance that masking should be mandatory in every form of public transportation. Masking has made an impact in keeping us safe through the entire pandemic. So, if we all continue to wear face coverings while taking public transportation, we will continue to be safe.
How safe is it for parents to send their kids to school?
All schools in New York City, private or public, should be following the guidelines set forth by the New York City Department of Education and the recommendations of the New York City Department of Health and Mental Hygiene. If I had a child who was school age, I would feel safe sending them to school based on those guidelines. I would also follow all the recommendations for parents made by those organizations. The New York City Department of Education summarizes much of the guidance here.
Are there any additional measures parents can take to protect their children?
It’s important that if your child is eligible to be vaccinated, you should vaccinate your child as soon as possible against COVID-19. And now that certain age groups are eligible to get the booster, parents should take advantage of that as well.
Have the recommendations changed in terms of what type of mask people should wear?
Because Omicron is more infectious, there have been some reports in the media that cloth masks may no longer be appropriate or adequate insofar as protecting us from this particular variant of COVID-19. But right now, we don’t have enough data to be sure. If people want to be better protected, they should first make sure their mask is well-fitted. You may want to consider double masking in which you would wear a medical or surgical mask underneath a cloth mask. This would simulate, or be equivalent to, a KN95 mask which is 95 percent effective in filtering respiratory droplets. But no matter what mask you wear, it will be ineffective if you don’t wear it properly—meaning that it should cover your nose and your mouth.
What should I do if I come into close contact with a person who is positive for COVID-19? What defines a close contact at this time?
If you haven’t received your booster shot, and you have a close contact with someone who has tested positive for COVID-19, you should quarantine for five days, according to new CDC recommendations. Afterwards, you should wear a mask in public for another five days. The CDC also recommends that you should get tested five days after the exposure. A high-risk contact or high-risk exposure is defined as being within six feet of someone who tested positive for COVID-19 for more than 15 minutes, and this could be cumulative over a 24-hour period. If you have received your booster shot, you do not need to quarantine following an exposure, but you should wear a mask for 10 days after the exposure and get tested at day 5 if you still do not have symptoms, according to the CDC. This is why it is important to get a booster shot as soon as you are eligible.
Is there anything else that has changed recently that people should know?
One thing that I want to highlight is the new CDC recommendation that if you were found to be infected with COVID-19, you only need to isolate for five days. To correctly count these five days, you should consider the date of symptom onset as Day Zero. If you are asymptomatic, Day Zero would be the date of your positive test. On the day after Day Five, you can leave isolation as long as you keep your mask on when you’re in public. And you should avoid places where you would have to take your mask off, such as restaurants.
Mount Sinai West earned a High Performing rating, the highest rating available, from U.S. News & World Report in the publication’s inaugural assessment of hospitals that provide obstetrical care. Mount Sinai West, along with Mount Sinai Morningside, which are ranked together, are among 237 of 2,700 hospitals in the United States to receive this rating.
The labor and delivery unit’s providers are also trained in TeamSTEPPS, a teamwork model developed by the U.S. Department of Defense and the Agency for Healthcare Research and Quality, to optimize patient outcomes by improving communication among providers.
